HISTORY OF PRESENT ILLNESS:   The patient is a 73 year old male with a history of metastatic melanoma admitted with acute renal failure, weakness, encephalopathy and hypotension.
The patient originally presented with a left forearm mass and was treated with excision and skin graft status post progression in [**2088**].
He had recurrence in [**2103**], and underwent a left axillary node dissection.
After this, he was treated with interferon therapy which was discontinued in [**2105-3-2**] when hepatic and meningeal metastases were discovered.
After this, he received [**Initials (NamePattern4) **] [**Last Name (NamePattern4) **] [**First Name4 (NamePattern1) 25368**] [**Last Name (NamePattern1) **]-chemotherapy protocol with two cycles of ......  therapy followed by a cycle of Biotherapy.
Initially, the patient appeared to improve on Taxol gaining weight and strength.
The patient was given intravenous fluids and his creatinine decreased from a peak of 3.4 to a level of 1.8 at discharge.
Over the week following discharge, the patient has had continued somnolence and decreased p.o.
In the Emergency Department, the patient received six liters of normal saline and 4 mg of dexamethasone for resuscitation.
He also received doses of Ceftriaxone and Levofloxacin.
MSIR 50 mg q. four to six hours p.r.n.
Also, in the differential was sepsis and adrenal insufficiency as well as cardiogenic process including pericardial tamponade.
The patient was treated with a aggressive fluid repletion with normal saline, with good response.
He was subsequently started on dexamethasone 0.5 mg q. h.s.
Following fluid repletion and improvement in the patient's blood pressure, the patient's renal function improved significantly.
A Foley catheter was placed to rule out any contribution of obstruction due to the patient's acute renal failure.
METASTATIC MELANOMA:  The patient was status post local resection as well as biochemotherapy by the [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 25368**] protocol.
He had most recently been treated with Taxol initially with good response and then with progression of his disease.
He was transfused with two units of packed red blood cells with an appropriate bump in his hematocrit.
URINARY TRACT INFECTION:  The patient was started on Levofloxacin for a urinary tract infection and will complete a seven day course as an outpatient.
intake during this admission and was continued on intravenous fluids.
The patient will be discharged with intravenous fluids which he can discontinue at his own discretion.
Thoracentesis was not pursued.
If the patient becomes hypoxic, the issue of therapeutic thoracentesis will need to be addressed with the family.
Protonix 40 mg q. day.
Tylenol p.r.n.
Levofloxacin 250 mg p.o.
Heparin subcutaneously 5000 units three times a day.
